rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11 Pt 1
|
pubmed:dateCreated |
2001-11-28
|
pubmed:abstractText |
Plasma levels of endogenous guanidine compounds are increased in various pathologic conditions, including chronic renal failure. In the present study we tested the effects of some of these compounds on basal and stimulated nitric oxide activity in human renal arteries.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0895-7061
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1142-8
|
pubmed:dateRevised |
2009-2-24
|
pubmed:meshHeading |
pubmed-meshheading:11724214-Acetylcholine,
pubmed-meshheading:11724214-Adult,
pubmed-meshheading:11724214-Aged,
pubmed-meshheading:11724214-Arginine,
pubmed-meshheading:11724214-Biological Markers,
pubmed-meshheading:11724214-Female,
pubmed-meshheading:11724214-Humans,
pubmed-meshheading:11724214-Male,
pubmed-meshheading:11724214-Middle Aged,
pubmed-meshheading:11724214-Nitric Oxide,
pubmed-meshheading:11724214-Renal Artery,
pubmed-meshheading:11724214-Risk Factors
|
pubmed:year |
2001
|
pubmed:articleTitle |
Inhibition of nitric oxide activity by arginine analogs in human renal arteries.
|
pubmed:affiliation |
Department of Fisiología, Universidad de Valencia, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|